Immunochina Company
Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.
Technology:
CAR-T therapy, Cell-based gene therapy, Regenerative Medicine
Industry:
Biotechnology, Clinical Trials, Medical, Medical Device, Pharmaceutical, Private
Headquarters:
Beijing, Beijing, China
Founded Date:
2015-04-01
Employees Number:
1-10
Funding Status:
Late Stage Venture
Investors Number:
12
Total Funding:
28064042
Last Funding Date:
2021-11-24
Last Funding Type:
Series D
Register and Claim Ownership